Ophthalmics Partnering & Dealmaking Trends Reviewed by CurrentPartnering in In-demand Study Published at MarketPublishers.com

27 Aug 2013 • by Natalie Aster

LONDON – The major portion of opthalmics partnering deals in the biopharma industry are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors psychiatry technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialisation of outcomes.

Knowing the flexibility of a would-be partner’s negotiated deals terms provides key insights into the negotiation process in terms of what is likely to be achieved during the negotiation of terms. Whilst smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered.

In-demand study “Ophthalmics Partnering Terms & Agreements” worked out by CurrentPartnering provides an in-depth understanding and unprecedented access to the latest opthalmics deals and contracts announced in the healthcare market worldwide, besides explaining how and why various opthalmics companies enter these deals.

Report Scope:

• overview of key trends and activities in opthalmics partnering and dealmaking since 2007; 
• analysis of financial deal terms by stage at signing, comprising headline value, upfront payment, milestone payments and royalty rates. 
• review of the top opthalmics deals by value since 2007; 
• comprehensive listing of the top 50 bigpharma and bigbiotech companies with extensive profiles of 20 opthalmics partnering companies; 
• comprehensive access to all opthalmics deals and contract documents since 2007; 
• insight into all opthalmics partnering deals by specific therapeutic target; 
• leading opthalmics partnering resources.

The available deals are listed by: company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing, etc) and technology type.

Report Details:

Ophthalmics Partnering Terms & Agreements
Published: July, 2013
Pages: 605
Price: US$ 2,995.00

Reports on Other Healthcare Partnering Deals & Agreements Include:

• Partnering Deals and Alliances with Big Pharma
• Manufacturing and Supply Partnering Terms and Agreements
• Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics
• Vaccine Partnering Terms and Agreements
• Diagnostics Partnering Terms and Agreements
• Drug Delivery Partnering Terms and Agreements

More in-demand studies by the publisher can be found at CurrentPartnering page.

CONTACTS

The Market Publishers, Ltd.
Tanya Levdikova
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com